Cantitate/Preț
Produs
Total produse
Vezi coșul
Drugs Targeting B-Cells in Autoimmune Diseases de Xavier Bosch

Drugs Targeting B-Cells in Autoimmune Diseases: Milestones in Drug Therapy

Editat de Xavier Bosch, Manuel Ramos-Casals, Munther A Khamashta
en Limba Engleză Hardback – 9 dec 2013
This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.
Citește tot Restrânge

Din seria Milestones in Drug Therapy

  • 5% Gene Therapy for Autoimmune and Inflammatory Diseases
    Preț: 135622 lei
  • 5% Treatment of Psoriasis
    Preț: 84004 lei
  • 5% Valproate
    Preț: 35786 lei
  • 5% Modern Immunosuppressives
    Preț: 35174 lei
  • 5% Cognitive Enhancing Drugs
    Preț: 68462 lei
  • 5% Fluoroquinolone Antibiotics
    Preț: 69447 lei
  • 5% Glucocorticoids
    Preț: 62461 lei
  • 5% Atypical Antipsychotics
    Preț: 135393 lei
  • 5% Glucocorticoids
    Preț: 35084 lei
  • 5% Pharmacotherapy of Obesity
    Preț: 66735 lei
  • 5% Glutamate-based Therapies for Psychiatric Disorders
    Preț: 105208 lei
  • 5% Methotrexate
    Preț: 34751 lei
  • 5% HMG-CoA Reductase Inhibitors
    Preț: 68180 lei
  • 5% ACE Inhibitors
    Preț: 35139 lei
  • 5% COX-2 Inhibitors
    Preț: 105770 lei
  • 5% Recombinant Protein Drugs
    Preț: 105561 lei
  • 5% Proton Pump Inhibitors
    Preț: 123540 lei
  • 5% Antidepressants
    Preț: 61723 lei
  • 5% Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use
    Preț: 105894 lei
  • 5% Sildenafil
    Preț: 154584 lei
  • 5% Twenty Years of G-CSF: Clinical and Nonclinical Discoveries
    Preț: 137169 lei
  • 5% Aromatase Inhibitors
    Preț: 67169 lei
  • 5% Anxiolytics
    Preț: 68338 lei
  • 5% Cannabinoids as Therapeutics
    Preț: 173317 lei
  • 5% Calcium Channel Blockers
    Preț: 105859 lei
  • 5% PEGylated Protein Drugs: Basic Science and Clinical Applications
    Preț: 136292 lei
  • 5% Hepatitis Prevention and Treatment
    Preț: 105119 lei
  • 5% Bortezomib in the Treatment of Multiple Myeloma
    Preț: 68956 lei
  • 5% Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology
    Preț: 69165 lei
  • 5% Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD
    Preț: 68832 lei
  • 5% Drugs for HER-2-positive Breast Cancer
    Preț: 104364 lei
  • 5% Combination Therapy of AIDS
    Preț: 105084 lei
  • 5% Influenza Virus Sialidase - A Drug Discovery Target
    Preț: 105159 lei
  • 5% Macrolide Antibiotics
    Preț: 106158 lei
  • 5% Tamoxifen: Pioneering Medicine in Breast Cancer
    Preț: 123714 lei

Preț: 106124 lei

Preț vechi: 111708 lei
-5% Nou

Puncte Express: 1592
Preț estimativ în valută:
20311€ • 21427$ • 16926£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783034807050
ISBN-10: 3034807058
Pagini: 300
Ilustrații: XI, 292 p. 3 illus., 2 illus. in color.
Dimensiuni: 155 x 235 x 2 mm
Greutate: 0.64 kg
Ediția:2014
Editura: Springer
Colecția Springer
Seria Milestones in Drug Therapy

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Historic outline of the development of drugs targeting B-cells.- Understanding B-cell biology.- Pharmacological effects and mechanisms of action of agents blocking B cells.- Systemic lupus erythematosus: direct B-cell blocking.- Systemic lupus erythematosus: indirect B-cell blocking.- B-cell targeted therapies in rheumatoid arthritis.- B-cell targeted therapies in Primary Sjögren Syndrome.- Targeting B cells in ANCA-associated vasculitis.- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies.- B-cell targeted therapies in cryoglobulinemia.- B-cell targeted therapies in autoimmune cytopenias and thrombosis.- Targeting B cells in neurological autoimmune diseases.- Targeting B cells in other systemic autoimmune diseases.- Safety of B-cell targeted therapies.- The future potential of biosimilars targeting B-cells.

Textul de pe ultima copertă

This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.

Caracteristici

Written and edited by leading international experts with long clinical experience Provides comprehensive background and practical information for scientists, clinicians and pharmaceutical companies Improves the understanding of and the decision for this new therapies of autoimmune diseases Includes supplementary material: sn.pub/extras